Persistence of the immune response after MenACWY-CRM vaccination and response to a booster dose, in adolescents, children and infants.

ABSTRACT: Persistence of bactericidal antibodies following vaccination is extremely important for protection against invasive meningococcal disease, given the epidemiology and rapid progression of meningococcal infection. We present an analysis of antibody persistence and booster response to MenACWY-CRM, in adolescents, children and infants, from 7 clinical studies. Immunogenicity was assessed using the serum bactericidal assay with both human and rabbit complement. Post-vaccination hSBA titers were high, with an age- and serogroup-specific decline in titers up to 1 y and stable levels up to 5 y The waning of hSBA titers over time was more pronounced among infants and toddlers and the greatest for serogroup A. However, rSBA titers against serogroup A were consistently higher and showed little declin

SUBMITTER: Baxter R 

PROVIDER: S-EPMC4963074 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature